Altimmune's obesity drug throws up safety concerns, shares plunge

[cafead]

via Altimmune Inc said on Tuesday that its obesity drug helped reduce patients' weight by about 10% on average in a mid-stage trial, but concerns over the drug's safety sent the company's shares tumbling nearly 40% in premarket trading.

article source